AI generated image of a bull running toward the photographer down a financial district. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Tamboran Resources (ASX:TBN) has announced it will list on the New York Stock Exchange (NYSE) at US$24/sh (A$36/sh) to fund development of the Beetaloo Basin in the NT.

The company is expected to be at the fore of development efforts in the onshore basin which is expected to potentially become Australia’s next major gasfield.

The NT government has been keenly supportive of greenfield efforts to get the basin into production, given flowbacks to the territory could be significant.

To this end Tamboran is listing 3.12M shares on the NYSE, ultimately seeking to raise US$75M. Those funds will go towards the Shenandoah South Pilot Project. Some US$20M is already locked in from existing major shareholders.

Tamboran boosted its stake in that project to 47.5% earlier this year, around the same time the company reported record gas flows in early stage operations on-site.

Shares will go live on the NYSE overnight Thursday Australian time.

Notable is the pedigree of uptown entities the listing has managed to interest. Bank of America, Citigroup and RBC Capital Markets are all on board as managers.

TBN last traded at 19cps.

TBN by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…